KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $165.4 million.

  • Bio-Rad Laboratories' Accumulated Depreciation & Amortization rose 910.29% to $165.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $165.4 million, marking a year-over-year increase of 910.29%. This contributed to the annual value of $165.4 million for FY2025, which is 910.29% up from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Accumulated Depreciation & Amortization is $165.4 million, which was up 910.29% from $151.6 million recorded in Q4 2024.
  • Bio-Rad Laboratories' Accumulated Depreciation & Amortization's 5-year high stood at $1.1 billion during Q2 2023, with a 5-year trough of $137.3 million in Q4 2022.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $971.9 million (2021), whereas its average is $700.2 million.
  • Within the past 5 years, the most significant YoY rise in Bio-Rad Laboratories' Accumulated Depreciation & Amortization was 269039.29% (2021), while the steepest drop was 72.15% (2021).
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Accumulated Depreciation & Amortization stood at $137.6 million in 2021, then fell by 0.22% to $137.3 million in 2022, then grew by 6.26% to $145.9 million in 2023, then grew by 3.91% to $151.6 million in 2024, then increased by 9.1% to $165.4 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $165.4 million for Q4 2025, versus $151.6 million for Q4 2024 and $145.9 million for Q4 2023.